Newcastle Upon Tyne, England, United Kingdom
I am currently CFO and a director of Ingenza Limited, a technology driven CRDMO located in its state-of-the-art facilities in Edinburgh. I also act as voluntary accountant to the Soko Fund, a Scottish charity which helps provide funding for females to undertake university education in Malawi.
ADVANCED BY NATURE Ingenza is a biotechnology company specialising in the design, development and manufacture of diverse, high-value industrial products and therapeutic-proteins. We exploit synergies between synthetic and evolutionary biology, providing next generation microbial and mammalian manufacturing platforms. What makes Ingenza unique? Dynamic teamwork forged from full integration between the in-house molecular biology, fermentation and chemistry teams, boosted by close ties to UK universities, provides the perfect skillsets to expertly guide you through your project. We can support you at any stage of development, from proof of concept to scaled-up manufacture under GMP conditions. Combining the old and the new Ingenza’s ethos is all about combining the best tried-and-tested traditional methods, the latest breakthroughs and technologies, and a healthy dose of experience and expertise, to bring refreshing innovation to the development of sustainable and cost-competitive biotechnology.
A specialist investment and advisory firm focused on established small-and-medium-size-enterprises with high growth potential in chemicals, materials, industrial biotech, pharma and medical technology sectors.
One of the UK’s leading private pathology organisations, providing high quality pathology services to the NHS and General Practitioners, the independent sector, and overseas clients for over 30 years.
I am a Chartered Accountant (FCA) working with a portfolio of SME clients for whom I provide senior financial support and guidance as they look to grow within their chosen sectors. I have over 25 years experience in senior finance roles across a range of business sectors, company sizes and ownership models (including Private Equity).
Following the Mayborn Group's private equity transaction, in 2007 I was offered a promotion into a group role as Group Financial Controller responsible for the financial accounting and reporting for the group's holding companies. In this role I established an efficient process for consolidating both management and statutory accounts for the multi-national, multi-currency group (T/O >£100m p.a.), drove forward the group's global transfer pricing projects, established processes to ensure the group best exploited the new UK patent box tax regime (saving >£0.5m in UK corporation tax liabilities in the first year), and efficiently administered all aspects of the group's bank and shareholder lending. I was appointed trustee of the defined benefit pension plan in 2007, becoming Chairman in 2009. Following a group refinancing exercise in 2012, I helped negotiate to secure additional employer funds to ensure the scheme remains one of the few fully funded defined benefit schemes in the country.